Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
59,600
+4,300 (7.78%)
Dec 10, 2025, 3:30 PM KST
174.65%
Market Cap2.12T
Revenue (ttm)23.23B
Net Income (ttm)-13.14B
Shares Out38.26M
EPS (ttm)-343.51
PE Ration/a
Forward PE247.98
Dividendn/a
Ex-Dividend Daten/a
Volume562,917
Average Volume629,975
Open56,800
Previous Close55,300
Day's Range56,500 - 60,500
52-Week Range21,850 - 65,000
Beta1.35
RSI60.28
Earnings DateNov 14, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.